Search

Search Results
Results 5811 - 5820 of 5870 for Mental illness
  • DBL Desferrioxamine Mesylate
    Drug - 19 Jan 2023
    Consumer Medicine Information (CMI) about DBL Desferrioxamine Mesylate (desferrioxamine mesilate) intended for persons living in Australia.
  • Perisyl Combi
    Drug - 6 Jan 2023
    Consumer Medicine Information (CMI) about Perisyl Combi (perindopril erbumine and indapamide hemihydrate) intended for persons living in Australia.
  • Juluca
    Drug - 16 Dec 2022
    Consumer Medicine Information (CMI) about Juluca intended for persons living in Australia.
  • Dilantin
    Drug - 30 Nov 2022
    Consumer Medicine Information (CMI) about Dilantin intended for persons living in Australia.
  • Rexulti
    Drug - 13 Nov 2022
    Consumer Medicine Information (CMI) about Rexulti intended for persons living in Australia.
  • Celsentri
    Drug - 11 Nov 2022
    Consumer Medicine Information (CMI) about Celsentri intended for persons living in Australia.
  • Lamivudine/Zidovudine Viatris 150/300
    Drug - 10 Nov 2022
    Consumer Medicine Information (CMI) about Lamivudine/Zidovudine Viatris 150/300 (lamivudine and zidovudine) intended for persons living in Australia.
  • Xalkori
    Drug - 8 Nov 2022
    Consumer Medicine Information (CMI) about Xalkori intended for persons living in Australia.
  • Diabex XR 500 and 1000
    Drug - 17 Oct 2022
    Consumer Medicine Information (CMI) about Diabex XR 500 and 1000 intended for persons living in Australia.
  • Diabex
    Drug - 14 Oct 2022
    Consumer Medicine Information (CMI) about Diabex intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback